Access cutting-edge bladder cancer treatment through this clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.
Access bladder cancer specialists in Chicago at no cost
This study follows strict safety protocols and ethical guidelines
All study-related bladder cancer treatment provided free
The goal of the study is to learn about the safety of Sacituzumab Tirumotecan and if people can tolerate it when given in the bladder and find the highest dose that people can take without having certain problems. Researchers will then choose a dose level of Sacituzumab Tirumotecan to use in future studies to learn how well the drug works.
Sponsor: Merck Sharp & Dohme LLC
Check if you qualify for this bladder cancer clinical trial in Chicago, IL
If you're searching for bladder cancer treatment options in Chicago, IL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Chicago research site is actively enrolling participants for this clinical trial. You'll receive care from experienced bladder cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.